Beam Therapeutics Inc (BEAM)
23.47
-0.63
(-2.61%)
USD |
NASDAQ |
Apr 23, 16:00
23.46
-0.01
(-0.04%)
After-Hours: 20:00
Beam Therapeutics Market Cap: 1.917B for April 23, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 23, 2024 | 1.917B |
| April 22, 2024 | 1.968B |
| April 19, 2024 | 1.952B |
| April 18, 2024 | 1.985B |
| April 17, 2024 | 1.985B |
| April 16, 2024 | 2.099B |
| April 15, 2024 | 2.099B |
| April 12, 2024 | 2.117B |
| April 11, 2024 | 2.227B |
| April 10, 2024 | 2.210B |
| April 09, 2024 | 2.394B |
| April 08, 2024 | 2.353B |
| April 05, 2024 | 2.303B |
| April 04, 2024 | 2.371B |
| April 03, 2024 | 2.424B |
| April 02, 2024 | 2.495B |
| April 01, 2024 | 2.667B |
| March 28, 2024 | 2.698B |
| March 27, 2024 | 2.773B |
| March 26, 2024 | 2.713B |
| March 25, 2024 | 2.751B |
| March 22, 2024 | 2.746B |
| March 21, 2024 | 2.854B |
| March 20, 2024 | 2.847B |
| March 19, 2024 | 2.845B |
| Date | Value |
|---|---|
| March 18, 2024 | 2.782B |
| March 15, 2024 | 2.891B |
| March 14, 2024 | 2.826B |
| March 13, 2024 | 3.052B |
| March 12, 2024 | 2.923B |
| March 11, 2024 | 2.986B |
| March 08, 2024 | 3.065B |
| March 07, 2024 | 3.018B |
| March 06, 2024 | 3.126B |
| March 05, 2024 | 3.145B |
| March 04, 2024 | 3.123B |
| March 01, 2024 | 3.253B |
| February 29, 2024 | 3.225B |
| February 28, 2024 | 3.561B |
| February 27, 2024 | 3.680B |
| February 26, 2024 | 2.923B |
| February 23, 2024 | 2.776B |
| February 22, 2024 | 2.739B |
| February 21, 2024 | 2.593B |
| February 20, 2024 | 2.597B |
| February 16, 2024 | 2.686B |
| February 15, 2024 | 2.696B |
| February 14, 2024 | 2.554B |
| February 13, 2024 | 2.447B |
| February 12, 2024 | 2.727B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
683.17M
Minimum
Mar 16 2020
8.611B
Maximum
Jul 01 2021
3.321B
Average
2.826B
Median
Market Cap Benchmarks
| Eli Lilly and Co | 708.98B |
| Moderna Inc | 41.31B |
| Pfizer Inc | 148.62B |
| Editas Medicine Inc | 446.70M |
| Intellia Therapeutics Inc | 2.069B |
Market Cap Related Metrics
| PS Ratio | 4.793 |
| Price to Book Value | 1.953 |
| Price | 23.47 |
| Earnings Yield | -8.10% |